ATE383369T1 - Neues peptid sy - Google Patents

Neues peptid sy

Info

Publication number
ATE383369T1
ATE383369T1 AT02793366T AT02793366T ATE383369T1 AT E383369 T1 ATE383369 T1 AT E383369T1 AT 02793366 T AT02793366 T AT 02793366T AT 02793366 T AT02793366 T AT 02793366T AT E383369 T1 ATE383369 T1 AT E383369T1
Authority
AT
Austria
Prior art keywords
peptide
blood pressure
fraction
water
elution
Prior art date
Application number
AT02793366T
Other languages
English (en)
Inventor
Katsuhiro Osajima
Yasunori Ooishi
Original Assignee
Senmi Ekisu Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senmi Ekisu Co Ltd filed Critical Senmi Ekisu Co Ltd
Application granted granted Critical
Publication of ATE383369T1 publication Critical patent/ATE383369T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/04—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from fish or other sea animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/857—Fish; fish eggs; shell fish; crustacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02793366T 2001-12-25 2002-12-24 Neues peptid sy ATE383369T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001392758 2001-12-25

Publications (1)

Publication Number Publication Date
ATE383369T1 true ATE383369T1 (de) 2008-01-15

Family

ID=19188685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02793366T ATE383369T1 (de) 2001-12-25 2002-12-24 Neues peptid sy

Country Status (11)

Country Link
US (1) US6905704B2 (de)
EP (1) EP1460084B1 (de)
JP (1) JP4087339B2 (de)
KR (1) KR100960843B1 (de)
AT (1) ATE383369T1 (de)
AU (1) AU2002360002A1 (de)
CA (1) CA2442194C (de)
DE (1) DE60224576T2 (de)
ES (1) ES2298415T3 (de)
PT (1) PT1460084E (de)
WO (1) WO2003055901A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006056805A (ja) * 2004-08-18 2006-03-02 Senmi Ekisu Co Ltd カルシウムチャンネル阻害剤
WO2006084383A1 (en) * 2005-02-14 2006-08-17 Ocean Nutrition Canada Limited Anti-diabetic or anti-hypertensive dietary supplement
US7179793B2 (en) 2005-02-14 2007-02-20 Ocean Nutrition Canada Limited Anti-hypertensive dietary supplement
JP5554719B2 (ja) * 2007-12-14 2014-07-23 ホフセス バイオケア エイエス 鉄分の吸収を促進するための方法及び組成物
US20120077747A1 (en) * 2008-10-23 2012-03-29 Innovactiv Inc. Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent
PL2948003T3 (pl) 2013-01-23 2021-01-25 Bottled Science Limited Kompozycja napoju poprawiająca skórę
US10694768B2 (en) 2014-04-28 2020-06-30 International Dehydrated Foods, Inc. Process for preparing a soluble protein composition
US10694767B2 (en) 2014-04-28 2020-06-30 International Dehydrated Foods, Inc. Process for preparing a pumpable broth composition
MX2016014147A (es) 2014-04-28 2017-02-15 Int Dehydrated Foods Inc Composiciones de proteina soluble y metodos para su elaboracion.
US11388910B2 (en) 2014-04-28 2022-07-19 International Dehydrated Foods, Inc. Process for preparing a collagen-rich composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62257360A (ja) * 1986-04-29 1987-11-09 Kazuharu Osajima 低分子量ペプチドを主成分とする呈味物質の製法
EP0283257B1 (de) * 1987-03-20 1993-01-13 Sumitomo Seika Chemicals Co., Ltd. Essbare Zusammensetzung
DE69124274T2 (de) 1990-02-27 1997-08-14 Agency Ind Science Techn Oligopeptide, sie enthaltende pharmazeutische und Futterzusammensetzung und Benützung von Oligopeptiden
JP3117779B2 (ja) 1992-02-24 2000-12-18 仙味エキス株式会社 新規ペプチドα−１０００
JP3388602B2 (ja) 1993-02-12 2003-03-24 仙味エキス株式会社 新規親水性ペプチド
JP3406341B2 (ja) 1993-02-19 2003-05-12 仙味エキス株式会社 新規ペプチド、その製法及び用途
JP3403794B2 (ja) 1994-01-27 2003-05-06 仙味エキス株式会社 血圧降下剤及び血圧降下性機能食品
JPH11228599A (ja) 1998-02-10 1999-08-24 Senmi Extract Kk 新規ペプチドｙ−２
JP4053686B2 (ja) 1999-04-28 2008-02-27 仙味エキス株式会社 生理活性健康食品

Also Published As

Publication number Publication date
AU2002360002A1 (en) 2003-07-15
EP1460084A4 (de) 2005-10-19
WO2003055901A1 (fr) 2003-07-10
EP1460084A1 (de) 2004-09-22
US20040087504A1 (en) 2004-05-06
ES2298415T3 (es) 2008-05-16
JPWO2003055901A1 (ja) 2005-05-12
CA2442194A1 (en) 2003-07-10
DE60224576T2 (de) 2009-01-08
EP1460084B1 (de) 2008-01-09
CA2442194C (en) 2011-06-07
PT1460084E (pt) 2008-04-17
US6905704B2 (en) 2005-06-14
KR100960843B1 (ko) 2010-06-07
KR20040067859A (ko) 2004-07-30
JP4087339B2 (ja) 2008-05-21
DE60224576D1 (de) 2008-02-21

Similar Documents

Publication Publication Date Title
MX9602259A (es) Proteina modificada quimicamente en el nitrogeno terminal, composiciones que las incluyen y metodos para su preparacion.
EP0984067A3 (de) Hepatitis C Virus Genotypsequenzen sowie ihre Verwendung als Behandlungs- und Nachweismitteln
EP1484339A3 (de) Kallikreinhemmende "Kunitz-Domäne"Proteine dafür kodierende Nukleinsäure
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
DE60129432D1 (de) Verfahren zur rückfaltung von proteinen mit freien cysteinresten
WO1995025749A3 (en) Eating suppressant peptides
ATE383369T1 (de) Neues peptid sy
WO2003037932A3 (en) Human coagulation factor vii polypeptides
WO1998021328A3 (en) Human proteins having transmembrane domains and dnas encoding these proteins
Nissen et al. Limited proteolysis of β2‐microglobulin at Lys‐58 by complement component C1s
WO2002048180A3 (de) Peptide und/oder proteine sowie verwendung desselben zur herstellung eines therapeutischen und/oder präventiven arzneimittels
EP1613345A4 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
ATE113074T1 (de) Neue aprotinin-varianten und gentechnisches verfahren zur mikrobiellen herstellung dieser varianten in homogen prozessierter form.
KR950702579A (ko) 트롬빈 억제제(thrombin inhibitors)
MY136546A (en) A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
ES2176334T3 (es) El uso de gabapentin en el tratamiento de la ansiedad y el panico.
UA84831C2 (ru) Производные фактора коагуляции vii
HK1031664A1 (en) Use of an organ-specific nutritional composition
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
Yagi et al. Purification and characterization of carboxyl proteinase from Aspergillus kawachii
Keller et al. Amino acid composition of the serum proteins. III. The chromatographic isolation of human and bovine serum albumins, and the amino composition of the fractions
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
ATE405584T1 (de) Arginin/lysin-angereicherte peptide
JPS51125790A (en) Carrier for fixing of biologically active substances
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties